
Paarsanova Pharmaceuticals Private Limited
Founded in 2015 and headquartered in Delhi, India.
Founded in 2015 and headquartered in Delhi, India.
Delhi, India
+91-XXXXXXXXXX
U74140DL2015PTC285612
285612
Private Limited Indian Non-Government Company
23 Sep 2015
30 Dec 2016
31 Mar 2016
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Tufail Ahmad ![]() | Director | 23-Sep-2015 | Current |
Rizwana Bi ![]() | Director | 23-Sep-2015 | Current |
Enhance accessibility to Paarsanova Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Paarsanova Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Paarsanova Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Paarsanova Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paarsanova Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Paarsanova Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Dec 2016 as per latest MCA records.
Paarsanova Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Delhi.
Tufail Ahmad was appointed as a Director was appointed as a Director on 23 Sep 2015 & has been associated with this company since 9 years 8 months .
Rizwana Bi was appointed as a Director was appointed as a Director on 23 Sep 2015 & has been associated with this company since 9 years 8 months .
Paarsanova Pharmaceuticals Private Limited was registered on 23 Sep 2015 with Roc Delhi & aged 9 years 8 months as per MCA records.
Paarsanova Pharmaceuticals Private Limited was incorporated on 23 Sep 2015.
The authorized share capital of Paarsanova Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Paarsanova Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Paarsanova Pharmaceuticals Private Limited is House No 378 Pkt 10 Sec 11 Rohini India, New Delhi, 110085.
The corporate identification number (CIN) of Paarsanova Pharmaceuticals Private Limited is U74140DL2015PTC285612 and the company number is 285612 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Paarsanova Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2016.
Search company & director profiles for free and gain access to critical business data.